hall 1 693 1 9699,	
obteniendoel71% 1 693 1 9404,	
>nivel 1 693 1 8864,	
deHBeAg 1 693 1 8820,	
[34-57 1 693 1 8421,	
	5 1 693 1 8177,	
18 1 693 1 8129,	
retardada 1 693 1 7177,	
individuos 1 693 1 7172,	
alérgica 1 693 1 7169,	
reacción 2 693 2 7168,7174,	
provocar 1 693 1 7166,	
sacarosa 1 693 1 7152,	
ml) 1 693 1 7147,	
informados 1 693 1 7135,	
sacarasa-isomaltasa 1 693 1 7124,	
galactosa 1 693 1 7120,	
glucosa 1 693 1 7118,	
fructosa 1 693 1 7112,	
raros 1 693 1 7106,	
problemas 2 693 2 7105,7113,	
(50 1 693 1 6214,	
mg) 2 693 2 6211,6215,	
(100 2 693 2 6210,7143,	
ml 2 693 2 6209,6213,	
20 3 693 3 6208,7146,9039,	
pálido 1 693 1 5725,	
amarillo 1 693 1 5724,	
incolora 1 693 1 5720,	
(E216) 1 693 1 5705,	
propilo 2 693 2 5704,7162,	
(E218) 1 693 1 5700,	
metilo 2 693 2 5699,7159,	
parahidroxibenzoato 3 693 3 5697,5702,7157,	
conservantes 1 693 1 5696,	
(sacarosa) 1 693 1 5694,	
Azúcar 1 693 1 5693,	
Excipientes 1 693 1 5692,	
contiene 3 693 3 5687,7148,7156,	
eu/ 1 693 1 5669,	
europa 1 693 1 5668,	
emea 1 693 1 5667,	
//www 1 693 1 5666,	
http 1 693 1 5665,	
(EMEA) 1 693 1 5664,	
Medicamentos 1 693 1 5663,	
Europea 1 693 1 5661,	
Agencia 1 693 1 5660,	
web 1 693 1 5657,	
página 1 693 1 5656,	
disponible 1 693 1 5653,	
detallada 1 693 1 5648,	
TEXTO 1 693 1 5645,	
REVISIÓN 1 693 1 5643,	
2004 1 693 1 5638,	
Julio 1 693 1 5627,	
29 2 693 2 5626,5636,	
autorización 2 693 2 5625,5635,	
AUTORIZACIÓN/RENOVACIÓN 1 693 1 5617,	
PRIMERA 1 693 1 5616,	
FECHA 2 693 2 5613,5640,	
EU/1/99/114/002 1 693 1 5611,	
NÚMERO(S) 1 693 1 5605,	
Unido 1 693 1 5602,	
0NN 1 693 1 5600,	
Road 1 693 1 5596,	
Greenford 2 693 2 5595,5597,	
Ltd 1 693 1 5594,	
	Glaxo 1 693 1 5592,	
COMERCIALIZACIÓN 2 693 2 5591,5609,	
AUTORIZACIÓN 3 693 3 5589,5607,5620,	
LA 4 693 4 5588,5615,5619,5642,	
locales 1 693 1 5584,	
exigencias 1 693 1 5583,	
envases 1 693 1 5576,	
productos 2 693 2 5570,7164,	
vinilo 1 693 1 5559,	
policloruro 1 693 1 5557,	
lámina 1 693 1 5554,	
alveolar 1 693 1 5550,	
embalaje 1 693 1 5549,	
84 1 693 1 5543,	
u 1 693 1 5542,	
Estuches 1 693 1 5539,	
recipiente 1 693 1 5538,	
Naturaleza 1 693 1 5534,	
30ºC 1 693 1 5531,	
temperatura 1 693 1 5528,	
conservación 1 693 1 5524,	
Precauciones 2 693 2 5521,5562,	
validez 1 693 1 5516,	
14 1 693 1 6008,	
Periodo 1 693 1 5514,	
procede 1 693 1 5511,	
Incompatibilidades 1 693 1 5509,	
Estearato 1 693 1 5504,	
sodio 1 693 1 5503,	
Carboximetilalmidón 1 693 1 5501,	
microcristalina 1 693 1 5500,	
Celulosa 1 693 1 5499,	
comprimido 1 693 1 5498,	
Núcleo 1 693 1 5496,	
Lista 1 693 1 5493,	
FARMACÉUTICOS 1 693 1 5490,	
carcinogénico 1 693 1 5487,	
ratones 1 693 1 5481,	
ratas 1 693 1 5479,	
carcinogenicidad 1 693 1 5471,	
sistémicas 1 693 1 5462,	
exposiciones 1 693 1 5461,	
alcanzados 1 693 1 5450,	
preñados 1 693 1 5442,	
embrioletalidad 1 693 1 5435,	
induce 1 693 1 5434,	
hembras 1 693 1 5432,	
machos 1 693 1 5430,	
teratogenicidad 1 693 1 5420,	
genotoxicidad 1 693 1 5402,	
concluye 1 693 1 5391,	
pudo 1 693 1 5383,	
previstos 1 693 1 5373,	
plasmáticos 1 693 1 5371,	
60-70 1 693 1 5364,	
dieron 1 693 1 5358,	
genotóxica 1 693 1 5352,	
ratón 1 693 1 5348,	
linfoma 1 693 1 5346,	
citogenético 1 693 1 5338,	
mostró 1 693 1 5333,	
Estos 2 693 2 5307,7163,	
neutropenia 1 693 1 5306,	
eritrocitos 1 693 1 5304,	
recuento 1 693 1 5302,	
apreciados 1 693 1 5296,	
importantes 1 693 1 5295,	
peso 1 693 1 5289,	
reducciones 1 693 1 5285,	
indicadores 1 693 1 5276,	
altas 2 693 2 5269,5464,	
preclínicos 1 693 1 5239,	
excepto 1 693 1 5220,	
acompaña 1 693 1 5209,	
envejecimiento 1 693 1 5198,	
farmacocinético 1 693 1 5192,	
perfil 1 693 1 5191,	
ancianos 1 693 1 5189,	
Es 1 693 1 5116,	
Poblaciones 1 693 1 5094,	
70 1 693 1 5087,	
representa 2 693 2 5084,5396,	
orgánico) 1 693 1 5080,	
(sistema 1 693 1 5076,	
orina 1 693 1 5069,	
excreta 1 693 1 5062,	
l/h/kg 1 693 1 5048,	
Eliminación 1 693 1 5036,	
(5-10%) 1 693 1 5027,	
excreción 1 693 1 5002,	
2-4 1 693 1 4983,	
LCR/concentración 1 693 1 4977,	
ratio 1 693 1 4976,	
(LCR) 1 693 1 4971,	
líquido 1 693 1 4969,	
alcanza 1 693 1 4967,	
nervioso 1 693 1 4963,	
19 1 693 1 8706,	
penetra 1 693 1 4959,	
muestran 1 693 1 4956,	
plasmáticas 3 693 3 4946,5035,5362,	
intervalo 1 693 1 4937,	
presenta 1 693 1 4929,	
l/kg 1 693 1 4927,	
distribución 1 693 1 4922,	
volumen 1 693 1 4919,	
intravenosa 1 693 1 4917,	
realizados 2 693 2 4912,5477,	
Distribución 1 693 1 4908,	
administrar 1 693 1 4903,	
AUC) 1 693 1 4892,	
absorbida 1 693 1 4888,	
cantidad 1 693 1 4885,	
47 1 693 1 4880,	
(reducida 1 693 1 4877,	
tmax 1 693 1 4871,	
retraso 1 693 1 4869,	
020 1 693 1 4857,	
015-0 1 693 1 4856,	
µg/ml 2 693 2 4849,4858,	
1-1 1 693 1 4847,	
decir 1 693 1 4833,	
(Cmax) 1 693 1 4823,	
máximas 1 693 1 4822,	
gastrointestinal 1 693 1 4791,	
24 1 693 1 4777,	
45% 1 693 1 4769,	
19% 1 693 1 4762,	
variando 1 693 1 4760,	
observada 2 693 2 4757,5053,	
057) 1 693 1 4744,	
lamivudina; 1 693 1 4742,	
(42/191) 1 693 1 4740,	
22% 1 693 1 4739,	
estadísticamente 1 693 1 4720,	
índices 2 693 2 4698,4726,	
acerca 1 693 1 4690,	
necesita 1 693 1 4686,	
diarios) 1 693 1 4657,	
(hasta 1 693 1 4651,	
empleó 1 693 1 4642,	
mínimo 1 693 1 4640,	
grado 2 693 2 4639,5023,	
compuesta 1 693 1 4631,	
comprendidas 2 693 2 4620,4662,	
edades 2 693 2 4619,4661,	
286 1 693 1 4616,	
mEq/ml) 1 693 1 4592,	
bDNA 1 693 1 4587,	
[versión 1 693 1 4584,	
(VERSANT 1 693 1 4583,	
convirtieron 1 693 1 4574,	
93% 1 693 1 4565,	
(118/252) 1 693 1 4556,	
confirmada 1 693 1 4552,	
respectivamente) 1 693 1 4546,	
11% 1 693 1 4541,	
5%) 1 693 1 4508,	
1] 1 693 1 4585,	
(11/221 1 693 1 4507,	
11%) 1 693 1 4494,	
tratado 3 693 3 4473,4523,4537,	
16/215 1 693 1 4457,	
9% 1 693 1 4454,	
(17/436 1 693 1 4452,	
hepatocelular 1 693 1 4451,	
023) 1 693 1 4444,	
19/215 1 693 1 4440,	
4% 2 693 2 4437,4459,	
Child-Pugh 1 693 1 4434,	
mutagénica 2 693 2 5321,5377,	
porcentaje 1 693 1 4423,	
001) 1 693 1 4415,	
p=0 4 693 4 4414,4443,4460,4743,	
38/215 1 693 1 4409,	
8% 2 693 2 4404,4442,	
(34/436 1 693 1 4402,	
media) 1 693 1 4391,	
(32 1 693 1 4387,	
confirmadas 1 693 1 4381,	
(nº 1 693 1 8807,	
significativo 2 693 2 5173,5214,	
651 1 693 1 4369,	
controlado 2 693 2 4365,4612,	
32%) 1 693 1 4351,	
Metabolismo 1 693 1 4996,	
(14% 1 693 1 4349,	
inmunocompetentes 1 693 1 4346,	
hígado 2 693 2 4341,5291,	
64%) 1 693 1 4334,	
(36% 1 693 1 4332,	
concomitante 1 693 1 4312,	
inmunodepresión 1 693 1 4311,	
esperar 1 693 1 4307,	
76-100% 1 693 1 4303,	
cabo 2 693 2 4297,4324,	
supervivencia 1 693 1 4295,	
tenía 1 693 1 4284,	
injerto 1 693 1 4278,	
reinfección 1 693 1 4276,	
continuaba 1 693 1 4269,	
valores 1 693 1 4264,	
eficaz 1 693 1 4254,	
significativamente 1 693 1 4393,	
supresión 1 693 1 4253,	
demostró 1 693 1 4251,	
administró 1 693 1 4243,	
inapropiados 1 693 1 4234,	
positivos) 1 693 1 4141,	
(HBeAg 1 693 1 4137,	
cuarenta 1 693 1 4135,	
abierto 1 693 1 4132,	
brazo 1 693 1 4131,	
incluyeron 1 693 1 4128,	
sola 1 693 1 4125,	
(3/47) 1 693 1 4121,	
combinada 1 693 1 4116,	
31% 1 693 1 4108,	
log10 3 693 3 4075,4086,4196,	
dipivoxilo 2 693 2 4047,4167,	
adefovir 2 693 2 4046,4166,	
10 4 693 4 4043,4163,5639,6212,	
(n=95) 1 693 1 4039,	
(NUC20904) 1 693 1 4029,	
ciego 1 693 1 4014,	
manejo 1 693 1 3994,	
Todavía 1 693 1 3988,	
hepáticos 1 693 1 3987,	
necroinflamatorios 1 693 1 3986,	
hallazgos 1 693 1 3985,	
elevación 2 693 2 3960,9673,	
asociado 2 693 2 3932,9645,	
aumentando 2 693 2 3914,9627,	
24% 2 693 2 3905,9618,	
aproximadamente 7 693 7 3903,4826,4992,5045,5085,5363,9616,	
da 2 693 2 3891,9604,	
monoterapia 3 693 3 3888,4096,9601,	
impacto 3 693 3 3881,5172,9594,	
Frecuencia 2 693 2 3871,9584,	
Ningún 2 693 2 3861,9574,	
(31%) 2 693 2 3853,9566,	
8/26 2 693 2 3852,9565,	
empeoraron 4 693 4 3830,3854,9543,9567,	
1/22 2 693 2 3828,9541,	
14/22 2 693 2 3818,9531,	
Datos 1 693 1 5238,	
(37%) 2 693 2 3808,9519,	
18/49 2 693 2 3807,9518,	
4/26 2 693 2 3842,9555,	
necroinflamación 6 693 6 3805,3826,3850,9516,9539,9563,	
bioquímica 1 693 1 4035,	
así 2 693 2 3797,9508,	
32/68 2 693 2 3791,9502,	
(43%) 2 693 2 3789,9500,	
detectó 4 693 4 3783,4485,4504,9494,	
Tras 3 693 3 3763,4808,9474,	
procedentes 2 693 2 3748,9459,	
(tmax) 1 693 1 4817,	
(70%) 2 693 2 3738,9449,	
interrumpió 2 693 2 3728,9439,	
IAH 2 693 2 3720,9431,	
38% 2 693 2 3716,9427,	
67% 4 693 4 3710,3917,9421,9630,	
71% 1 693 1 3694,	
obteniendo 1 693 1 3692,	
iniciales 2 693 2 3669,9381,	
OMS 2 693 2 3654,9366,	
modificado 2 693 2 3651,9363,	
criterio 2 693 2 3650,9362,	
histológicamente 1 693 1 4382,	
acuerdo 3 693 3 3648,5580,9360,	
Grado 2 693 2 3645,9357,	
Toxicidad 2 693 2 3643,9355,	
representado 2 693 2 3635,9347,	
>2 2 693 2 3622,9334,	
basal; 2 693 2 3619,9331,	
8/116 2 693 2 3613,9325,	
(15%) 4 693 4 3612,3843,9324,9556,	
21/137 2 693 2 3611,9323,	
absoluta>500 2 693 2 3609,9321,	
(8%) 2 693 2 3601,9313,	
(21%) 2 693 2 3599,9311,	
ocasionales 1 693 1 5286,	
29/137 2 693 2 3598,9310,	
22/116 2 693 2 3591,9303,	
= 3 693 3 3656,7145,9368,	
(27%) 2 693 2 3590,9302,	
(15/436 1 693 1 4435,	
37/137 2 693 2 3589,9301,	
Anormal 2 693 2 3581,9293,	
ALT/ 2 693 2 3579,9291,	
Elevación 2 693 2 3577,9289,	
Pacientes 3 693 3 3575,8805,9287,	
Elevaciones 2 693 2 3563,9275,	
baja 4 693 4 3550,4948,5019,9262,	
proporción 2 693 2 3531,9243,	
recibieron 8 693 8 3521,3556,4093,4114,4123,4571,9233,9268,	
semana 3 693 3 3512,4765,9224,	
68 2 693 2 3503,9215,	
52 8 693 8 3501,3513,4060,4180,4326,4766,9213,9225,	
absorbe 1 693 1 4786,	
comparación 4 693 4 3491,4078,4496,9203,	
muestra 2 693 2 3489,9201,	
recibido 4 693 4 3475,3482,9187,9194,	
iniciarlo 2 693 2 3460,9172,	
semanas 7 693 7 3450,3500,4061,4181,4327,9162,9212,	
16 3 693 3 3449,7101,9161,	
control 2 693 2 3440,9152,	
reanudación 2 693 2 3438,9150,	
re- 2 693 2 3422,9135,	
debería 2 693 2 3419,9132,	
constante 2 693 2 3418,9131,	
Placebo 2 693 2 3583,9295,	
mantengan 2 693 2 3414,9127,	
mantienen 2 693 2 3409,9122,	
pequeño 1 693 1 5022,	
respuestas 2 693 2 3404,9117,	
sujetos 2 693 2 3386,9099,	
39% 2 693 2 3383,9096,	
ocurrió 2 693 2 3380,9093,	
interrumpieron 4 693 4 3371,3507,9084,9219,	
seguimiento 4 693 4 3364,3447,9077,9159,	
plazo 3 693 3 3362,5474,9075,	
(47%) 2 693 2 3792,9503,	
recaídas 2 693 2 3353,9066,	
ocurrir 2 693 2 3352,9065,	
duraderas 2 693 2 3342,9055,	
clínica 4 693 4 3339,3407,9052,9120,	
remisión 2 693 2 3338,9051,	
serológica 6 693 6 3335,3405,3417,9048,9118,9130,	
Después 2 693 2 3327,9040,	
(7%) 4 693 4 3325,3614,9037,9326,	
2/27 2 693 2 3324,9036,	
(74%) 2 693 2 3316,9028,	
20/27 2 693 2 3315,9027,	
(23%) 2 693 2 3306,9018,	
9/39 2 693 2 3305,9017,	
necroinflamatoria 4 693 4 3303,3322,9015,9034,	
(46%) 2 693 2 3296,9008,	
status 2 693 2 3276,8988,	
Meq/ml) 2 693 2 3267,8979,	
0 7 693 7 3265,4084,4590,4855,4994,5046,8977,	
Quantiplex 2 693 2 3263,8975,	
pg/ml) 2 693 2 3259,8971,	
(LLOD 4 693 4 3255,3264,8967,8976,	
Ensayo 4 693 4 3248,3261,8960,8973,	
Límite 4 693 4 3244,3657,8956,9369,	
momento 2 693 2 3232,8944,	
salvaje 2 693 2 3229,8941,	
tipo 2 693 2 3228,8940,	
95% 2 693 2 3226,8938,	
-YMDD 1 693 1 3221,	
período 4 693 4 3209,3527,8920,9239,	
instante 2 693 2 3204,8915,	
categorizados 4 693 4 3189,3217,8899,8928,	
Normalización 2 693 2 3157,8866,	
positivo 4 693 4 3149,3153,8859,8863,	
Semana 4 693 4 3145,3168,8855,8878,	
Basal 4 693 4 3142,3160,8852,8870,	
(1/18) 2 693 2 3140,8850,	
(2/40) 2 693 2 3138,8848,	
límite 2 693 2 3704,9415,	
detectable 2 693 2 3136,8846,	
> 7 693 7 3128,3154,3184,3225,8838,8894,8937,	
LNS2 2 693 2 3124,8834,	
basal 20 693 20 3121,3127,3152,3156,3178,3186,3588,3597,3606,3629,8831,8837,8862,8865,8888,8896,9300,9309,9318,9341,	
Todos 2 693 2 3116,8826,	
(13/18) 2 693 2 3114,8824,	
72 2 693 2 3113,8823,	
38 2 693 2 3111,8821,	
Seroconversión 2 693 2 3108,8819,	
HBV 1 693 1 3107,	
Estado 2 693 2 3104,8812,	
No-YMDD1 1 693 1 3103,	
orden 1 693 1 4844,	
YMDD1 3 693 3 3102,8809,8811,	
NUCB3018 2 693 2 3101,8804,	
asiático) 2 693 2 3100,8803,	
(Estudio 2 693 2 3099,8802,	
Resultados 2 693 2 3088,8791,	
resultados 3 693 3 3075,5466,8779,	
últimos 2 693 2 3074,8778,	
resumen 2 693 2 3072,8776,	
indetectables 2 693 2 3058,8762,	
TITULAR 1 693 1 5586,	
tuvieron 6 693 6 3052,3368,3535,8756,9081,9247,	
Al 2 693 2 3043,8747,	
LNS 8 693 8 3042,3131,3624,3655,8746,8841,9336,9367,	
>2x 2 693 2 3041,8745,	
central 1 693 1 4964,	
previos 6 693 6 3038,3064,3970,8742,8768,9684,	
cefalorraquídeo 1 693 1 4970,	
(20/26) 2 693 2 3030,8734,	
77% 2 693 2 3029,8733,	
seroconvirtieron 2 693 2 3027,8731,	
ALT; 4 693 4 3026,3713,8730,9424,	
aumentó 2 693 2 3019,8723,	
respectivamente 4 693 4 3014,3796,8718,9507,	
(15/32) 2 693 2 3013,8717,	
47% 3 693 3 3012,4555,8716,	
(28/58) 2 693 2 3010,8714,	
48 2 693 2 3008,8712,	
periodo 4 693 4 3000,3237,8703,8949,	
final 4 693 4 2998,3044,8701,8748,	
normalización 8 693 8 2994,3711,3774,4098,4261,8697,9422,9485,	
velocidad 4 693 4 2992,4395,4463,8695,	
tasa 10 693 10 2985,3803,3824,3848,4293,4314,8688,9514,9537,9561,	
(NUCB3018) 2 693 2 2983,8686,	
asiáticos 2 693 2 2982,8685,	
estudio 17 693 17 2976,3211,3242,3359,3751,3770,4012,4134,4364,4582,4611,8679,8922,8954,9072,9462,9481,	
progresó 4 693 4 2971,3868,8674,9581,	
(6%) 2 693 2 2956,8659,	
administra 1 693 1 5439,	
4/68 2 693 2 2955,8658,	
pre-tratamiento 6 693 6 2947,3836,3860,8650,9549,9573,	
(11/82) 2 693 2 2928,8630,	
13 2 693 2 2926,8628,	
5% 4 693 4 2915,3196,8617,8906,	
(63%) 2 693 2 2897,8598,	
19/30 2 693 2 2896,8597,	
(71%) 2 693 2 2876,8577,	
40/56 2 693 2 2875,8576,	
(50%) 4 693 4 2868,2907,8569,8609,	
41/82 2 693 2 2867,8568,	
mejoría 17 693 17 2854,2887,3299,3318,3718,3800,3821,3845,4202,8555,8588,9011,9030,9429,9511,9534,9558,	
dio 5 693 5 2849,4062,4182,4865,8550,	
primer 2 693 2 2843,8544,	
lograron 2 693 2 2836,8537,	
continuo 2 693 2 2825,8526,	
3-17 2 693 2 2814,8515,	
progresión 12 693 12 2809,2820,2949,3974,4397,4465,4512,4530,8510,8521,8652,9688,	
redujo 3 693 3 2807,4392,8508,	
bacterias 1 693 1 5326,	
[IAH]) 2 693 2 2805,8506,	
Knodell 2 693 2 2804,8505,	
Histológica 2 693 2 2802,8503,	
Actividad 2 693 2 2801,8502,	
Índice 2 693 2 2799,8500,	
puntos 2 693 2 2796,8497,	
superior 8 693 8 2793,3246,3659,4331,5529,8494,8958,9371,	
descenso 3 693 3 2790,4186,8491,	
tenían 2 693 2 2788,8489,	
(38-52 2 693 2 2784,8485,	
80-85 1 693 1 4806,	
y/o 2 693 2 3982,9696,	
histología 2 693 2 2783,8484,	
mejoró 2 693 2 2781,8482,	
convencional] 2 693 2 2776,8477,	
ensayo 8 693 8 2775,3077,4586,5337,5344,8435,8476,8781,	
[por 2 693 2 2774,8475,	
HBeAc 2 693 2 2767,8468,	
pacientes) 6 693 6 2755,2780,2817,8456,8481,8518,	
volvieron 2 693 2 3739,9450,	
nivel 9 693 9 2749,3151,3155,3177,3185,8450,8861,8887,8895,	
normalizó 2 693 2 2747,8448,	
6pg/ml)} 2 693 2 2746,8447,	
LLOD 3 693 3 2743,4588,8444,	
Genostics 4 693 4 2742,3254,8443,8966,	
terapéutico 1 693 1 3995,	
Abbott 4 693 4 2741,3253,8442,8965,	
hibridación 4 693 4 2737,3250,8438,8962,	
(ensayo 2 693 2 2735,8436,	
g 1 693 1 7150,	
límites 2 693 2 2732,8431,	
estaban 2 693 2 2727,8426,	
34-57 1 693 1 2722,	
[ 1 693 1 2721,	
suprimió 2 693 2 2711,8411,	
comparables 1 693 1 5447,	
año 17 693 17 2708,2844,3206,3234,3457,3723,3911,4209,4300,4730,8408,8545,8917,8946,9169,9434,9624,	
gamma 2 693 2 2685,8385,	
incorpora 2 693 2 2670,8370,	
disminuir 2 693 2 2662,8362,	
potencial 3 693 3 2658,5486,8358,	
Presenta 2 693 2 2656,8356,	
tóxicos 2 693 2 2654,8354,	
carecía 2 693 2 2651,8351,	
3mg/kg 1 693 1 4646,	
vio 3 693 3 2648,4895,8348,	
mitocondrial 8 693 8 2638,2667,2676,2687,8338,8367,8376,8387,	
estructura 2 693 2 2637,8337,	
post-tratamiento 8 693 8 3470,3497,3539,3566,9182,9209,9251,9278,	
potenciales 2 693 2 2630,8330,	
relativos 2 693 2 2627,8327,	
contenido 7 693 7 2616,2642,2664,5536,8316,8342,8364,	
escaso 2 693 2 2612,8312,	
Además 2 693 2 2608,8308,	
mamíferos 4 693 4 2607,2623,8307,8323,	
polimerasas 2 693 2 2605,8305,	
beta 2 693 2 2603,8303,	
alfa 2 693 2 2601,8301,	
inhibidor 4 693 4 2598,2681,8298,8381,	
débil 2 693 2 2597,8297,	
También 6 693 6 2594,3268,4126,4198,8294,8980,	
puntuación 1 693 1 4432,	
deoxinucleótidos 2 693 2 2593,8293,	
normal 17 693 17 2590,3161,3166,3170,3175,3183,3245,3658,5199,8290,8871,8876,8880,8885,8893,8957,9370,	
celular 2 693 2 2589,8289,	
interfiere 2 693 2 2585,8285,	
Absorción 1 693 1 4783,	
Lamivudina-TP 2 693 2 2583,8283,	
terminación 2 693 2 2579,8279,	
posterior 4 693 4 2578,3379,8278,9092,	
cadena 2 693 2 2576,8276,	
suprimido 2 693 2 3700,9411,	
lamivudina-TP 4 693 4 2573,2609,8273,8309,	
bloquea 2 693 2 2569,8269,	
formación 2 693 2 2563,8263,	
polimerasa 4 693 4 2558,2686,8258,8386,	
sustrato 2 693 2 2555,8255,	
actúa 4 693 4 2553,2679,8253,8379,	
-TP 2 693 2 2552,8252,	
vitro 4 693 4 2550,5340,5379,8250,	
in 6 693 6 2549,5339,5353,5378,5388,8249,	
horas 4 693 4 2548,4984,5059,8248,	
17-19 2 693 2 2547,8247,	
semivida 3 693 3 2538,5050,8238,	
13% 1 693 1 4733,	
original 2 693 2 2536,8236,	
compuesto 2 693 2 2535,8235,	
(TP) 2 693 2 2528,8228,	
trifosfato 4 693 4 2527,2541,8227,8241,	
derivado 2 693 2 2526,8226,	
infectadas 4 693 4 2520,2524,8220,8224,	
células 4 693 4 2519,2621,8219,8321,	
metabolizada 2 693 2 2516,8216,	
experimentalmente 2 693 2 2513,8213,	
estudiadas 2 693 2 2508,8208,	
celulares 2 693 2 2507,8207,	
líneas 2 693 2 2506,8206,	
J05AF05 2 693 2 2488,8188,	
ATC 2 693 2 2487,8187,	
código 2 693 2 2486,8186,	
farmacoterapéutico 2 693 2 2482,8182,	
Grupo 2 693 2 2481,8181,	
farmacodinámicas 2 693 2 2480,8180,	
conservar 1 693 1 5526,	
Propiedades 3 693 3 2479,4781,8179,	
	 1 693 1 2475,	
ESTE 2 693 2 2473,8175,	
FARMACOLÓGICAS 2 693 2 2471,8173,	
PROPIEDADES 2 693 2 2470,8172,	
estudiado 2 693 2 2468,8170,	
sobredosificación 2 693 2 2462,8164,	
continua 2 693 2 2456,8158,	
emplearse 2 693 2 2453,8155,	
dializable 2 693 2 2451,8153,	
Dado 2 693 2 2447,8149,	
apoyo 2 693 2 2442,8144,	
vigilará 2 693 2 2433,8135,	
caso 2 693 2 2429,8131,	
específicos 2 693 2 2423,8124,	
nucleósido 2 693 2 2485,8185,	
síntomas 4 693 4 2420,3978,8121,9692,	
recuperaron 2 693 2 2415,8116,	
fallecimientos 2 693 2 2409,8110,	
hubo 2 693 2 2408,8109,	
agudas 2 693 2 2404,8105,	
sobredosis 6 693 6 2403,2427,2431,8104,8128,8133,	
ingestión 2 693 2 2401,8102,	
consecuencias 2 693 2 2398,8099,	
produjo 7 693 7 2386,2894,2953,4105,8087,8595,8656,	
elevadas 4 693 4 2382,5255,5367,8083,	
aguda 2 693 2 2376,8077,	
6% 1 693 1 4120,	
(40-72 2 693 2 2752,8453,	
Sobredosis 2 693 2 2369,8070,	
9 4 693 4 2368,4092,5612,8069,	
medio 6 693 6 4082,4187,4816,4920,4974,5040,	
recibían 2 693 2 2359,8060,	
análogos 3 693 3 2341,5330,8042,	
biodisponibilidad 1 693 1 4794,	
terapia 9 693 9 2337,3913,3922,3973,4115,8038,9626,9635,9687,	
relacionada 2 693 2 2326,8027,	
normalmente 3 693 3 2325,4803,8026,	
láctica 4 693 4 2324,2355,8025,8056,	
renovación 1 693 1 5632,	
9/116 2 693 2 3600,9312,	
acidosis 4 693 4 2323,2354,8024,8055,	
	6 1 693 1 5491,	
mortales 2 693 2 2321,8022,	
diferencias 2 693 2 2297,7998,	
hereditaria 1 693 1 7109,	
parestesia) 2 693 2 2287,7988,	
(o 2 693 2 2286,7987,	
neuropatía 2 693 2 2284,7985,	
pancreatitis 2 693 2 2282,7983,	
casos 6 693 6 2280,2318,2352,7981,8019,8053,	
comunicado 6 693 6 2279,2317,2350,7980,8018,8051,	
rabdomiolisis 2 693 2 2270,7971,	
calambres 2 693 2 2268,7969,	
mialgia 2 693 2 2267,7968,	
musculares 2 693 2 2265,7966,	
Frecuentes 2 693 2 2258,7959,	
tejido 2 693 2 2256,7957,	
musculoesqueléticos 2 693 2 2253,7954,	
raramente 4 693 4 2243,2351,7944,8052,	
remitido 2 693 2 2240,7941,	
detectadas 2 693 2 2226,7927,	
(15/40) 2 693 2 3112,8822,	
exacerbaciones 2 693 2 2222,7923,	
notificado 2 693 2 2221,7922,	
copias/ml 3 693 3 4076,4087,4197,	
apartado 2 693 2 2207,7908,	
Incrementos 4 693 4 2203,2259,7904,7960,	
Middlesex 1 693 1 5598,	
hepatobiliares 2 693 2 2200,7901,	
Muy 6 693 6 2196,2201,2262,7897,7902,7963,	
linfático 2 693 2 2195,7896,	
Trastornos 8 693 8 2188,2199,2252,2264,7889,7900,7953,7965,	
clasificaron 2 693 2 2182,7883,	
22/44 2 693 2 2906,8608,	
comercialización 2 693 2 2180,7881,	
post- 2 693 2 2179,7880,	
continuada 1 693 1 4775,	
vigilancia 2 693 2 2178,7879,	
identificadas 2 693 2 2175,7876,	
fármaco 2 693 2 2174,7875,	
grupos 4 693 4 2166,3867,7867,9580,	
mejoraron 4 693 4 2869,2885,8570,8586,	
previa 2 693 2 2163,7864,	
ensayos 3 693 3 2153,5324,7854,	
partir 2 693 2 2149,7850,	
determinaron 2 693 2 2147,7848,	
calcular 2 693 2 2131,7832,	
conejos 1 693 1 5441,	
adecuados 2 693 2 2129,7830,	
	Prospectos 1 693 1 9700,	
estimadas 2 693 2 2117,7818,	
siguientes 2 693 2 2113,7814,	
asignadas 2 693 2 2110,7811,	
000) 2 693 2 2105,7806,	
nucleósidos 3 693 3 2343,5332,8044,	
(< 2 693 2 2103,7804,	
1/1000) 2 693 2 2100,7801,	
000 2 693 2 2098,7799,	
1/10 4 693 4 2097,2104,7798,7805,	
raras 12 693 12 2095,2102,2184,2187,2197,2263,7796,7803,7885,7888,7898,7964,	
Group 1 693 1 5593,	
óptimo 1 693 1 3996,	
1/1000 2 693 2 2092,7793,	
experimentaron 5 693 5 3297,3317,4427,9009,9029,	
< 15 693 15 2087,2093,2099,2744,3150,3176,3256,4589,7788,7794,7800,8445,8860,8886,8968,	
1/100 2 693 2 2086,7787,	
actividad 6 693 6 3302,3321,5334,5376,9014,9033,	
1/10) 4 693 4 2083,2088,7784,7789,	
( 8 693 8 2082,2085,2091,2096,7783,7786,7792,7797,	
frecuentes 12 693 12 2081,2084,2090,2143,2145,2202,7782,7785,7791,7844,7846,7903,	
definen 2 693 2 2078,7779,	
relacionadas 2 693 2 2072,7773,	
posiblemente 2 693 2 2071,7772,	
consideradas 2 693 2 2068,7769,	
únicamente 2 693 2 2063,7764,	
asignan 2 693 2 2062,7763,	
categorías 6 693 6 2058,2107,3640,7759,7808,9352,	
indujo 2 693 2 2756,8457,	
Las 10 693 10 2057,2075,2106,2134,2170,7758,7776,7807,7835,7871,	
órgano 5 693 5 2054,2390,5263,7755,8091,	
Fecha 2 693 2 5621,5629,	
(320/345) 1 693 1 4566,	
corporal 2 693 2 2053,7754,	
clasificadas 4 693 4 2050,2140,7751,7841,	
continuación 2 693 2 2044,7745,	
UI/l 2 693 2 3610,9322,	
A 4 693 4 2043,4829,5265,7744,	
diarrea 2 693 2 2042,7743,	
vómitos 2 693 2 2040,7741,	
abdominales 2 693 2 2038,7739,	
dolor 2 693 2 2035,7736,	
cefalea 2 693 2 2034,7735,	
amígdalas 2 693 2 2033,7734,	
vivo 2 693 2 5354,5389,	
garganta 2 693 2 2031,7732,	
molestias 4 693 4 2028,2037,7729,7738,	
respiratorio 2 693 2 2027,7728,	
intolerancia 1 693 1 7108,	
tracto 3 693 3 2026,4790,7727,	
infecciones 2 693 2 2024,7725,	
(64%) 2 693 2 3819,9532,	
fatiga 2 693 2 2023,7724,	
malestar 2 693 2 2021,7722,	
comunes 2 693 2 2019,7720,	
comunicados 2 693 2 2017,7718,	
placebo 21 693 21 2008,2169,2309,3483,3522,3560,3572,4231,4367,4413,4539,4614,4715,4736,7709,7870,8010,9195,9234,9272,9284,	
habían 4 693 4 3474,3481,9186,9193,	
tratados 14 693 14 2006,2011,2167,2307,2312,3759,4560,4772,7707,7712,7868,8008,8013,9470,	
similar 7 693 7 2002,3552,3683,4754,7703,9264,9395,	
CPK 4 693 4 1997,2261,7698,7962,	
Reino 1 693 1 5601,	
incrementos 2 693 2 1993,7694,	
rata 1 693 1 5458,	
excepción 2 693 2 1990,7691,	
1999 1 693 1 5628,	
(a 2 693 2 1989,7690,	
anormalidades 2 693 2 1986,7687,	
media 1 693 1 4067,	
adversos 4 693 4 1984,2016,7685,7717,	
efectos 14 693 14 1983,2015,2303,2631,2653,5272,5293,5308,5425,7684,7716,8004,8331,8353,	
incidencia 9 693 9 1981,2133,2162,2300,4746,7682,7834,7863,8001,	
Reacciones 2 693 2 1965,7666,	
8 5 693 5 1964,3423,4441,5604,7665,	
máquinas 4 693 4 1949,1962,7650,7663,	
conducir 4 693 4 1946,1959,7647,7660,	
Efectos 2 693 2 1941,7642,	
7 10 693 10 1940,3085,3266,4403,4458,4591,5058,5585,7641,8978,	
amamanten 2 693 2 1935,7635,	
madres 2 693 2 1929,7629,	
humana 2 693 2 1913,7613,	
leche 2 693 2 1912,7612,	
excretada 2 693 2 1909,7609,	
Lactancia 2 693 2 1902,7602,	
embarazo 2 693 2 1897,7597,	
primeros 2 693 2 1894,7594,	
tres 2 693 2 1893,7593,	
predictivos 2 693 2 1880,7580,	
reproducción 3 693 3 1874,5412,7574,	
Aunque 2 693 2 1870,7570,	
parto 2 693 2 1869,7569,	
lineal 1 693 1 4932,	
umbilical 2 693 2 1866,7566,	
cordón 2 693 2 1865,7565,	
madre 2 693 2 1862,7562,	
similares 4 693 4 1853,1916,7553,7616,	
nacer 2 693 2 1851,7551,	
niño 2 693 2 1849,7549,	
placenta 2 693 2 1840,7540,	
Comparable 2 693 2 3641,9353,	
pasiva 2 693 2 1832,7532,	
consecuencia 2 693 2 1828,7528,	
Como 4 693 4 1827,4304,5374,7527,	
humanos 6 693 6 1826,1885,2406,7526,7585,8107,	
seres 2 693 2 1825,7525,	
reproductiva 2 693 2 1815,7515,	
toxicidad 8 693 8 1814,2375,2387,5250,5260,7514,8076,8088,	
mostrado 4 693 4 1813,5417,5424,7513,	
lactancia 2 693 2 1794,7494,	
Embarazo 4 693 4 1792,1795,7492,7495,	
18% 1 693 1 4545,	
utilización 4 693 4 1783,1802,7483,7502,	
utilizan 2 693 2 1772,7472,	
zalcitabina 4 693 4 1767,1789,7467,7489,	
intracelular 4 693 4 1765,2539,7465,8239,	
fosforilación 2 693 2 1764,7464,	
debajo 4 693 4 2729,3702,8428,9413,	
inhibir 2 693 2 1762,7462,	
hepatocitos 2 693 2 2544,8244,	
formales 2 693 2 1757,7457,	
A) 2 693 2 1749,7449,	
ciclosporina 2 693 2 1748,7448,	
(p 2 693 2 1746,7446,	
utilizados 3 693 3 1745,5572,7445,	
Límpida 1 693 1 5719,	
comúnmente 2 693 2 1744,7444,	
periférica 2 693 2 2285,7986,	
tomando 2 693 2 1736,7436,	
adversas 14 693 14 1731,1966,2049,2067,2115,2139,2172,7431,7667,7750,7768,7816,7840,7873,	
administran 2 693 2 1723,7423,	
interferón-alfa 2 693 2 1718,7418,	
farmacocinéticas 3 693 3 1716,4782,7416,	
ejerce 2 693 2 1714,7414,	
) 4 693 4 1711,6402,7411,8808,	
apreciables 2 693 2 2655,8355,	
carece 3 693 3 1699,5210,7399,	
Zidovudina 2 693 2 1698,7398,	
observaron 6 693 6 1729,2296,5271,5310,7429,7997,	
alteró 2 693 2 1694,7394,	
general 2 693 2 1690,7390,	
(28 2 693 2 1679,7379,	
(12/95) 1 693 1 4734,	
Cmax 4 693 4 1678,4841,4875,7378,	
incremento 2 693 2 1673,7373,	
modesto 2 693 2 1672,7372,	
observó 5 693 5 1670,3772,4200,7370,9483,	
presente 2 693 2 1658,7358,	
obstante 5 693 5 1652,1751,4883,7352,7451,	
sulfametoxazol 2 693 2 1650,7350,	
ningún 7 693 7 1642,2389,2966,5262,7342,8090,8669,	
negativo 2 693 2 3148,8858,	
ejerció 2 693 2 1641,7341,	
Lamivudina 23 693 23 1639,1712,1760,1967,2489,2514,2551,3582,4784,4928,4997,5060,5318,5349,5433,7339,7412,7460,7668,8189,8214,8251,9294,	
30/69 2 693 2 3788,9499,	
% 19 693 19 1638,2723,2753,2778,2785,2815,2927,3009,4807,5088,7338,8422,8454,8479,8486,8516,8629,8713,8806,	
40 2 693 2 1637,7337,	
alrededor 2 693 2 1634,7334,	
global 2 693 2 4398,4466,	
(NUCAB3017) 2 693 2 3762,9473,	
exposición 6 693 6 1630,1689,5217,5446,7330,7389,	
incrementó 2 693 2 1628,7328,	
mg/800 2 693 2 1626,7326,	
160 2 693 2 1625,7325,	
trimetoprima/sulfametoxazol 2 693 2 1624,7324,	
significativas 4 693 4 1618,1733,7318,7433,	
den 2 693 2 1613,7313,	
glomerular 3 693 3 1612,5072,7312,	
filtración 3 693 3 1611,5071,7311,	
aniónica 2 693 2 1606,7306,	
excretarse 2 693 2 1600,7300,	
hayan 2 693 2 1598,7298,	
sustancias 3 693 3 1596,5017,7296,	
probable 2 693 2 1594,7294,	
interaccionar 2 693 2 1589,7289,	
demostraron 2 693 2 1587,7287,	
parte 3 693 3 1585,5066,7285,	
mecanismo 2 693 2 1582,7282,	
eliminan 2 693 2 1579,7279,	
cimetidina) 2 693 2 1577,7277,	
sistémico 1 693 1 5039,	
ranitidina 2 693 2 1576,7276,	
ej 4 693 4 1575,1747,7275,7447,	
(por 2 693 2 1574,7274,	
ejemplo 2 693 2 1569,7269,	
catiónico 3 693 3 1567,5079,7267,	
hora 1 693 1 4828,	
transporte 3 693 3 1566,5078,7266,	
sistema 7 693 7 1564,2052,2194,4962,7264,7753,7895,	
vía 8 693 8 1554,1605,4798,4812,4916,4989,7254,7305,	
principal 3 693 3 1553,5264,7253,	
especialmente 2 693 2 1550,7250,	
administrados 2 693 2 1546,7246,	
posibilidad 2 693 2 1539,7239,	
(5%) 2 693 2 3829,9542,	
orgánica 4 693 4 1534,1607,7234,7307,	
catiónica 2 693 2 1533,7233,	
secreción 5 693 5 1532,1559,5074,7232,7259,	
predominantemente 2 693 2 1530,7230,	
elimina 3 693 3 1529,4999,7229,	
inalterada 4 693 4 1525,5007,5067,7225,	
sustancia 7 693 7 1524,1835,2634,5006,7224,7535,8334,	
eliminación 9 693 9 1520,1556,5052,5091,5106,5565,5567,7220,7256,	
magnesio 1 693 1 5506,	
generalmente 2 693 2 3341,9054,	
260 4 693 4 3146,3169,8856,8879,	
proteínas 4 693 4 1513,4945,5034,7213,	
unión 4 693 4 1511,4943,5032,7211,	
metabolismo 5 693 5 1509,2588,5025,7209,8288,	
047) 1 693 1 4461,	
hepatomegalia 2 693 2 2328,8029,	
escasa 3 693 3 1506,5031,7206,	
metabólicas 3 693 3 1504,5012,7204,	
probabilidad 3 693 3 1501,5009,7201,	
realizado 7 693 7 1496,1755,1953,4227,7196,7455,7654,	
interacciones 13 693 13 1493,1503,1541,1616,1715,1730,5011,7193,7203,7241,7316,7415,7430,	
estudios 32 693 32 1491,1756,1809,1872,1954,1972,2373,2626,2702,2847,3519,3569,4228,4236,4911,5097,5248,5316,5409,5469,7191,7456,7509,7572,7655,7673,8074,8326,8402,8548,9231,9281,	
interacción 4 693 4 1489,1759,7189,7459,	
Chiron 2 693 2 3262,8974,	
formas 2 693 2 1487,7187,	
Interacción 2 693 2 1480,7180,	
adecuadas 2 693 2 1476,7100,	
tomarse 2 693 2 1473,7097,	
mínimos 1 693 1 4853,	
deberán 2 693 2 1472,7096,	
incorporación 2 693 2 2571,8271,	
personas 2 693 2 1468,7092,	
demostrado 5 693 5 1454,1599,4416,7078,7299,	
informarse 2 693 2 1442,7066,	
frente 10 693 10 1432,2496,4117,4407,4438,4455,4542,4737,7056,8196,	
inmunización 2 693 2 1431,7055,	
establecerá 1 693 1 5578,	
recomendados 2 693 2 1429,7053,	
18/39 2 693 2 3295,9007,	
estándar 4 693 4 1428,2443,7052,8145,	
puente 4 693 4 2859,2892,8560,8593,	
procedimientos 2 693 2 1427,7051,	
seguir 2 693 2 1425,7049,	
mujeres 4 693 4 1415,1806,7039,7506,	
virus 8 693 8 1409,1434,1461,2498,7033,7058,7085,8198,	
fetal 2 693 2 1407,7031,	
materno 2 693 2 1406,7030,	
transmisión 6 693 6 1405,1459,1831,7029,7083,7531,	
dispone 12 693 12 1400,2126,2392,3270,3745,4955,5154,7024,7827,8093,8982,9456,	
Transmisión 2 693 2 1394,7017,	
sólo 8 693 8 1384,1497,1583,3283,7007,7197,7283,8995,	
utilizar 6 693 6 1383,1948,1961,7006,7649,7662,	
mutación 2 693 2 1379,7002,	
antirretroviral 2 693 2 1374,6997,	
antirretrovirales) 2 693 2 1359,6982,	
capacidad 4 693 4 1944,1957,7645,7658,	
mg/dos 2 693 2 1351,6974,	
150 2 693 2 1350,6973,	
infección 4 693 4 1346,2274,6969,7975,	
7% 1 693 1 4411,	
prescrita 2 693 2 1343,6966,	
mantenerse 2 693 2 1338,6961,	
recibir 2 693 2 1328,6951,	
planes 2 693 2 1327,6950,	
recibiendo 2 693 2 1322,6945,	
estén 4 693 4 1321,1418,6944,7042,	
infectados 6 693 6 1312,1363,2512,6935,6986,8212,	
VIH 14 693 14 1306,1318,1348,1369,1381,2276,2347,6929,6941,6971,6992,7004,7977,8048,	
Co-infección 2 693 2 1304,6927,	
signos 6 693 6 1286,2422,3976,6909,8123,9690,	
experimenten 2 693 2 1285,6908,	
posible 2 693 2 1281,6904,	
antígeno/anticuerpo 2 693 2 1269,6892,	
situación 2 693 2 1267,6890,	
sangre 4 693 4 1264,2191,6887,7892,	
ureico 2 693 2 1262,6885,	
nitrógeno 2 693 2 1261,6884,	
encontradas 4 693 4 1856,1919,7556,7619,	
albúmina 2 693 2 1260,6883,	
embarazadas 4 693 4 1416,1807,7040,7507,	
bilirrubina 6 693 6 1259,3548,3621,6882,9260,9333,	
mínimo) 2 693 2 1255,6878,	
(como 2 693 2 1254,6877,	
carcinoma 1 693 1 4450,	
incluir 2 693 2 1253,6876,	
razón 2 693 2 1237,6860,	
mes) 2 693 2 1228,6851,	
(al 2 693 2 1225,6848,	
antiviral 6 693 6 1221,2493,3434,6844,8193,9146,	
funciones 3 693 3 1215,5279,6838,	
asociados 2 693 2 1210,6833,	
permanente 2 693 2 2673,8373,	
serológicos 2 693 2 1209,6832,	
virológicos 2 693 2 1207,6830,	
clínicos 8 693 8 1206,1973,2154,5317,5372,6829,7674,7855,	
parámetros 4 693 4 1205,1247,6828,6870,	
controlar 6 693 6 1203,1251,1297,6826,6874,6920,	
deberían 4 693 4 1202,1252,6825,6875,	
mortal 2 693 2 1197,6820,	
e 6 693 6 1195,3370,3880,6818,9083,9593,	
descompensación 3 693 3 1193,4222,6816,	
tolerada 2 693 2 1970,7671,	
inducir 2 693 2 1191,6814,	
interrumpir 4 693 4 1177,3344,6800,9057,	
reactivación 2 693 2 1172,6795,	
Debido 2 693 2 1160,6783,	
mayor 9 693 9 1154,2853,3465,4287,4477,5065,6777,8554,9177,	
presentan 4 693 4 1152,2046,6775,7747,	
diabéticos 1 693 1 7132,	
avanzada 3 693 3 1151,4359,6774,	
aplicará 2 693 2 2438,8140,	
post 2 693 2 1139,6762,	
presenten 2 693 2 1134,6757,	
reiniciación 2 693 2 1126,6749,	
- 17 693 17 3115,3119,3125,3141,3144,3159,3167,4333,4350,8825,8829,8835,8851,8854,8869,8877,8932,	
beneficios 2 693 2 1123,6746,	
suficientes 4 693 4 1120,1799,6743,7499,	
existen 4 693 4 1118,1797,6741,7497,	
16-18 2 693 2 2777,8478,	
combinación 8 693 8 1335,1356,1787,2339,6958,6979,7487,8040,	
muertes 4 693 4 1116,2247,6739,7948,	
observado 6 693 6 1114,2246,3463,6737,7947,9175,	
autolimitadas 1 693 1 1109,	
reacciones 14 693 14 1106,2048,2066,2114,2123,2138,2171,6729,7749,7767,7815,7824,7839,7872,	
mayoría 8 693 8 1103,2120,2238,3734,6726,7821,7939,9445,	
Clínica 4 693 4 1101,2689,6724,8389,	
Experiencia 11 693 11 1100,2688,2690,3660,4212,4352,4593,6723,8388,8390,9372,	
Sección 2 693 2 1097,6720,	
véase 2 693 2 1091,6714,	
frecuencia 11 693 11 1083,1300,2056,2060,3466,5313,6706,6923,7757,7761,9178,	
referente 2 693 2 1080,6703,	
además 2 693 2 1069,6692,	
sido 4 693 4 1061,1108,6684,6731,	
análogo 2 693 2 2483,8183,	
náuseas 2 693 2 2039,7740,	
La 43 693 43 1055,1102,1500,1526,1621,1980,2237,2370,2537,2562,2886,2948,3015,3530,4097,4160,4462,4547,4628,4694,4745,4859,5008,5049,5136,5242,5566,5646,6678,6725,7153,7200,7226,7321,7681,7938,8071,8237,8262,8587,8651,8719,9242,	
clínicamente 9 693 9 1053,1617,1732,4375,5213,5294,6676,7317,7432,	
según 10 693 10 1051,1301,3078,3094,3274,6674,6924,8782,8797,8986,	
conocer 1 693 1 4687,	
luego 2 693 2 1050,6673,	
hombre 1 693 1 5453,	
cuatro 2 693 2 1047,6670,	
auto­limitadas 1 693 1 6732,	
bilirrubina) 2 693 2 1043,6666,	
(niveles 2 693 2 1039,6662,	
función 10 693 10 1035,1166,2644,4205,4890,5167,5205,6658,6789,8344,	
pruebas 3 693 3 1032,5387,6655,	
evaluación 4 693 4 1029,3280,6652,8992,	
controlarse 2 693 2 1015,6638,	
laboratorio 6 693 6 1004,1249,1988,6627,6872,7689,	
clínico 6 693 6 1001,1023,3441,6624,6646,9153,	
UB6 1 693 1 5599,	
vista 4 693 4 1000,1022,6623,6645,	
punto 4 693 4 998,1020,6621,6643,	
sintomatología 4 693 4 991,1135,6614,6758,	
presentar 4 693 4 990,3741,6613,9452,	
descompensada) 2 693 2 940,6564,	
cirrosis 12 693 12 939,2822,2951,2973,3870,4361,4380,6563,8523,8654,8676,9583,	
(aumento 2 693 2 933,6557,	
empeoramiento 10 693 10 929,2937,3308,3326,3983,6553,8640,9020,9038,9697,	
re-emergencia 4 693 4 915,1072,6539,6695,	
elevaciones 12 693 12 910,1065,1085,3467,3494,3536,6534,6688,6708,9179,9206,9248,	
principalmente 10 693 10 908,1063,1601,2227,4632,5000,6532,6686,7301,7928,	
detectada 4 693 4 907,1062,6531,6685,	
exacerbación 4 693 4 903,1056,6527,6679,	
VHB) 2 693 2 887,6511,	
(variante 2 693 2 884,6508,	
reducida 3 693 3 881,4036,6505,	
sensibilidad 2 693 2 880,6504,	
virales 2 693 2 875,6499,	
subpoblaciones 2 693 2 874,6498,	
identificado 4 693 4 873,2419,6497,8120,	
(en 3 693 3 2813,4889,8514,	
han 33 693 33 872,1107,1113,1495,1754,1812,1952,2220,2239,2245,2278,2316,2349,2418,3462,4226,5416,5423,6496,6730,6736,7195,7454,7512,7653,7921,7940,7946,7979,8017,8050,8119,9174,	
prolongado 6 693 6 870,2979,3754,6494,8682,9465,	
Con 2 693 2 867,6491,	
Exacerbaciones 2 693 2 863,6487,	
determinar 4 693 4 852,3401,6476,9114,	
intervalos 2 693 2 845,6469,	
monitorizarse 2 693 2 838,6462,	
zidovudina 2 693 2 1682,7382,	
Deben 1 693 1 837,	
regular 2 693 2 836,6460,	
Durante 4 693 4 824,2210,6448,7911,	
cáncer 2 693 2 822,6447,	
concurrentes 1 693 1 818,	
inmunodepresores 4 693 4 817,1743,6443,7443,	
reciben 2 693 2 815,6441,	
mutante 2 693 2 809,6435,	
(con 2 693 2 808,6434,	
relación 2 693 2 799,6425,	
limitados 8 693 8 797,1514,2395,4951,5150,6423,7214,8096,	
son 8 693 8 796,1878,2116,3340,6422,7578,7817,9053,	
C 2 693 2 793,6419,	
Delta 2 693 2 790,6416,	
coinfectados 2 693 2 787,6413,	
comparativos 2 693 2 3273,8985,	
establecido 3 693 3 780,3992,6406,	
actualmente 2 693 2 772,6397,	
población 5 693 5 766,4337,4629,4724,6391,	
limitaciones 2 693 2 756,6381,	
embargo 7 693 7 752,1111,3350,4510,6377,6734,9063,	
Sin 5 693 5 751,3349,4509,6376,9062,	
administrado 3 693 3 735,4600,6360,	
julio 1 693 1 5637,	
Se 20 693 20 733,1423,1669,1820,1922,2315,2348,2391,3744,4641,4685,6358,7047,7369,7520,7622,8016,8049,8092,9455,	
precauciones 4 693 4 729,1475,6354,7099,	
Advertencias 2 693 2 727,6352,	
activo 4 693 4 718,2495,6343,8195,	
principio 2 693 2 717,6342,	
Hipersensibilidad 2 693 2 715,6340,	
Contraindicaciones 2 693 2 714,6339,	
esté 9 693 9 707,1052,1302,1324,5182,6332,6675,6925,6947,	
necesario 7 693 7 695,1663,2446,5117,6320,7363,8148,	
Según 3 693 3 690,4909,6315,	
disfunción 4 693 4 688,5114,5185,6313,	
significativa 8 693 8 685,1697,2714,4420,4721,6310,7397,8414,	
mayores) 2 693 2 743,6368,	
afectada 5 693 5 682,4896,5111,5143,6307,	
ve 4 693 4 681,5110,5142,6306,	
farmacocinética 9 693 9 676,1646,1704,4931,5137,5176,6301,7346,7404,	
demuestran 4 693 4 673,5103,5161,6298,	
trasplante 10 693 10 672,946,1144,4249,4274,4339,5159,6297,6570,6767,	
espera 2 693 2 670,6295,	
terminal 2 693 2 667,6292,	
fase 2 693 2 666,6291,	
doble 2 693 2 4013,5553,	
incluyendo 6 693 6 660,819,2266,6285,6444,7967,	
animales 10 693 10 1811,1876,2378,2511,5252,5414,7511,7576,8079,8211,	
obtenidos 2 693 2 654,6279,	
diálisis 2 693 2 649,6274,	
1/100) 2 693 2 2094,7795,	
ajustes 2 693 2 641,6266,	
precisan 2 693 2 640,6265,	
paciente 12 693 12 637,1657,2435,2967,3632,3862,6262,7357,8137,8670,9344,9575,	
ajustar 6 693 6 631,696,1664,6256,6321,7364,	
asoció 1 693 1 5258,	
inicial 2 693 2 627,6252,	
séricas 1 693 1 4821,	
semana) 2 693 2 618,6243,	
veces 7 693 7 615,1352,2320,5365,6240,6975,8021,	
%) 3 693 3 1680,4881,7380,	
2-3 2 693 2 614,6239,	
h 2 693 2 613,6238,	
igual 2 693 2 610,6235,	
(diálisis 2 693 2 607,6232,	
intermitente 2 693 2 606,6231,	
reducción 8 693 8 623,1163,3935,4419,5299,6248,6786,9648,	
hemodiálisis 4 693 4 605,2455,6230,8157,	
sometidos 4 693 4 603,5157,5405,6228,	
disponibles 2 693 2 600,6225,	
Los 28 693 28 598,794,1141,1246,1282,1490,1808,2014,3187,3215,4949,5096,5148,5292,5408,5465,6223,6420,6764,6869,6905,7102,7130,7190,7508,7715,8897,8926,	
mg/ml 3 693 3 595,5676,5689,	
especiales 5 693 5 730,5095,5522,5563,6355,	
conteniendo 2 693 2 593,5540,	
acompañada 3 693 3 708,5183,6333,	
*Zeffix 1 693 1 590,	
<15 2 693 2 588,6221,	
<30 2 693 2 585,6218,	
15 2 693 2 583,6216,	
<50 2 693 2 582,6207,	
30 2 693 2 580,6205,	
sea 4 693 4 1557,2445,7257,8147,	
* 3 693 3 575,3630,9342,	
(3/56) 2 693 2 2919,8621,	
ml/min 4 693 4 572,5131,5231,6198,	
mantenimiento 2 693 2 571,6197,	
retirada 2 693 2 2216,7917,	
Dosis 2 693 2 569,6195,	
Primera 2 693 2 565,6191,	
(normalmente 2 693 2 1349,6972,	
Aclaramiento 2 693 2 562,6188,	
disminuido 2 693 2 561,6187,	
Dosificación 2 693 2 553,6179,	
continuación) 4 693 4 550,2000,6176,7701,	
Tabla 14 693 14 547,551,1093,3069,3086,3486,3561,6173,6177,6716,8773,8789,9198,9273,	
(ver 4 693 4 546,2206,6172,7907,	
conjuntivo 2 693 2 2257,7958,	
oral 14 693 14 545,574,592,1906,4799,4813,4990,5678,5686,5718,6200,7142,7155,7606,	
solución 12 693 12 544,573,591,2739,3252,5677,5685,6199,7141,7154,8440,8964,	
3) 2 693 2 1819,7519,	
utilizarse 1 693 1 542,	
inferiores 1 693 1 537,	
precisen 3 693 3 535,1372,6995,	
Cuando 4 693 4 533,3726,4267,9437,	
ml/minuto 2 693 2 532,6171,	
50 4 693 4 531,5130,5230,6170,	
inferior 5 693 5 529,4876,5128,5228,6168,	
máximo 1 693 1 4653,	
creatinina 10 693 10 528,564,635,1265,5127,5227,6167,6190,6260,6888,	
reducirse 2 693 2 519,6158,	
Por 6 693 6 515,1776,3387,6154,7476,9100,	
diferencia 1 693 1 4695,	
aclaramiento 12 693 12 513,526,559,633,5038,5082,5125,5225,6152,6165,6185,6258,	
disminución 4 693 4 511,4066,5202,6150,	
primera 1 693 1 5624,	
grave 6 693 6 507,1194,2329,6146,6817,8030,	
moderada 2 693 2 505,6144,	
insuficiencia 16 693 16 503,658,702,710,1288,1659,5101,5146,5164,6142,6283,6327,6335,6911,7122,7359,	
aumentan 2 693 2 499,6138,	
(AUC) 4 693 4 498,1691,6137,7391,	
suero 16 693 16 497,1038,1258,1274,1847,1859,1921,2236,6136,6661,6881,6897,7547,7559,7621,7937,	
concentraciones 12 693 12 493,1272,1842,1915,2232,4820,5361,6132,6895,7542,7615,7933,	
renal 25 693 25 491,504,514,560,711,1216,1521,1560,1660,5003,5083,5102,5115,5186,5206,5282,6130,6143,6153,6186,6336,6839,7221,7260,7360,	
Insuficiencia 4 693 4 490,650,6129,6275,	
seguridad 3 693 3 483,5241,6122,	
ausencia 3 693 3 479,5484,6118,	
debido 12 693 12 476,508,753,974,1507,4308,5020,6115,6147,6378,6597,7207,	
años 28 693 28 468,475,741,2830,3005,3048,3093,3214,3240,3286,3765,3920,4627,4667,4682,5518,6107,6114,6366,8531,8709,8752,8796,8925,8952,8998,9476,9633,	
indican 4 693 4 619,3670,6244,9382,	
menores 5 693 5 465,3060,5273,6104,8764,	
quimioterapia 2 693 2 820,6445,	
niños 12 693 12 464,738,1440,1938,4595,4603,4634,4659,6103,6363,7064,7638,	
recomendado 2 693 2 460,6099,	
17 7 693 7 455,474,4410,4626,6094,6113,7639,	
(de 4 693 4 452,739,6091,6364,	
adolescentes 9 693 9 451,470,745,4597,4605,4679,6090,6109,6370,	
años) 4 693 4 449,456,6088,6095,	
12 11 693 11 448,453,467,472,4681,4995,5603,6087,6092,6106,6111,	
(menores 2 693 2 446,6085,	
Niños 2 693 2 445,6084,	
(blister) 1 693 1 5551,	
4) 9 693 9 444,1901,2209,2251,4009,6083,7601,7910,7952,	
recurrente 9 693 9 440,944,994,1138,4150,6079,6568,6617,6761,	
existencia 2 693 2 436,6075,	
administrando 1 693 1 4270,	
comprobar 2 693 2 434,6073,	
periódicamente 6 693 6 432,1016,3399,6071,6639,9112,	
controlados 14 693 14 431,833,2703,2848,3398,3570,4229,4238,6070,6457,8403,8549,9111,9282,	
interrumpe 8 693 8 422,962,1007,1232,6061,6585,6630,6855,	
alternativos 2 693 2 415,6054,	
adicionales 4 693 4 413,644,6052,6269,	
tratamientos 4 693 4 412,816,6051,6442,	
deben 17 693 17 410,429,831,851,1014,1296,1424,3396,6049,6068,6455,6637,6919,7048,7126,7133,9109,	
aparición 8 693 8 400,3873,3895,4316,5400,6039,9586,9608,	
atribuible 2 693 2 397,6036,	
eficacia 14 693 14 396,485,782,973,1186,3090,3673,6035,6124,6408,6596,6809,8793,9385,	
pérdida 9 693 9 394,971,1184,2769,4288,6033,6594,6807,8470,	
produce 4 693 4 392,969,6031,6592,	
Si 8 693 8 390,420,960,1005,6029,6059,6583,6628,	
hepático 7 693 7 389,947,4154,5026,5160,6028,6571,	
transplante 3 693 3 388,4153,6027,	
confirmarse 1 693 1 5384,	
receptores 4 693 4 386,1142,6025,6765,	
enfermedad 19 693 19 381,663,931,1149,2698,3980,4026,4144,4216,4401,4469,4515,4533,6020,6288,6555,6772,8398,9694,	
indica 1 693 1 5195,	
lamivudina/zidovudina 2 693 2 1336,6959,	
recomienda 8 693 8 373,1781,1888,1923,6012,7481,7588,7623,	
No 26 693 26 371,777,1117,1398,1592,1651,1727,1750,1950,2407,2416,4882,5510,5525,6010,6403,6740,7022,7292,7351,7427,7450,7651,8108,8117,8810,	
alternativo 6 693 6 365,959,3435,6003,6582,9147,	
agente 8 693 8 364,958,2492,3433,6002,6581,8192,9145,	
adición 6 693 6 361,955,4041,4161,5999,6578,	
Cada 2 693 2 3631,9343,	
cambio 4 693 4 357,951,5996,6575,	
prolongada 2 693 2 347,5986,	
anteriores 2 693 2 339,5978,	
respecto 10 693 10 335,2943,3832,3856,3966,5974,8646,9545,9569,9680,	
ALT 58 693 58 333,842,912,935,1041,1067,1087,1256,1995,2205,2234,2751,2996,3037,3120,3126,3158,3469,3496,3538,3565,3584,3593,3602,3608,3615,3779,3965,4103,4266,5972,6466,6536,6559,6664,6690,6710,6879,7696,7906,7935,8452,8699,8741,8830,8836,8868,9181,9208,9250,9277,9296,9305,9314,9320,9327,9490,9678,	
frecuencias 6 693 6 2076,2109,2135,7777,7810,7836,	
aumento 10 693 10 325,2229,3543,3950,4081,4429,5965,7930,9255,9663,	
(los 1 693 1 4725,	
indicada 2 693 2 322,5962,	
terapéutica 2 693 2 319,5959,	
38/214 1 693 1 4544,	
respuesta 15 693 15 318,1220,1883,3334,3416,3884,3938,4032,5958,6843,7583,9047,9129,9597,9651,	
menor 6 693 6 317,608,4283,4527,5957,6233,	
dar 4 693 4 313,900,5953,6524,	
existe 2 693 2 1375,6998,	
YMDD 56 693 56 309,351,404,885,896,925,980,2864,2882,2904,2923,2935,2963,3084,3098,3106,3192,3198,3277,3292,3815,3877,3899,3928,4003,4022,4159,4320,4488,4519,4750,5949,5990,6043,6509,6520,6549,6603,8565,8583,8605,8625,8637,8666,8788,8801,8816,8902,8909,8933,8989,9004,9528,9590,9612,9641,	
variante 59 693 59 308,350,403,895,924,979,2863,2881,2903,2913,2922,2934,2962,2970,3083,3105,3191,3197,3220,3291,3314,3814,3841,3876,3898,3927,4002,4021,4158,4319,4487,4506,4749,5948,5989,6042,6519,6548,6602,8564,8582,8604,8615,8624,8636,8665,8673,8787,8815,8901,8908,8931,9003,9026,9527,9554,9589,9611,9640,	
desarrollo 9 693 9 305,892,976,3924,4448,5945,6516,6599,9637,	
EU/1/99/114/001 1 693 1 5610,	
interrupción 6 693 6 285,375,3453,5925,6014,9165,	
considerarse 13 693 13 283,355,411,949,1537,3420,4233,5923,5994,6050,6573,7237,9133,	
practique 2 693 2 647,6272,	
Debe 7 693 7 282,1441,1536,5922,6461,7065,7236,	
óptima 2 693 2 279,5919,	
duración 5 693 5 278,346,4390,5918,5985,	
desconoce 4 693 4 276,1821,5916,7521,	
pre-core) 4 693 4 274,810,5914,6436,	
(mutante 2 693 2 273,5913,	
esteatosis 2 693 2 2331,8032,	
través 4 693 4 1026,1837,6649,7537,	
negativos 14 693 14 272,303,807,3666,3681,3758,4138,4579,5912,5943,6433,9378,9393,9469,	
HBC 16 693 16 270,297,2694,3664,3679,3689,4018,4348,4356,4607,5910,5937,8394,9376,9391,9401,	
1) 6 693 6 265,369,419,776,6007,6058,	
5 43 693 43 264,368,418,488,586,594,775,1098,1479,1709,1818,2469,2477,3004,3047,3092,3137,3213,3239,4779,4848,5056,5236,5533,5675,5688,5904,6006,6057,6127,6219,6400,6721,7179,7409,7518,8171,8708,8751,8795,8847,8924,8951,	
	Solución 1 693 1 5717,	
(véase 25 693 25 262,366,416,441,486,773,983,1707,1816,1898,2248,4006,5132,5232,5902,6004,6055,6080,6125,6398,6606,7407,7516,7598,7949,	
(14/45) 1 693 1 4109,	
datos 33 693 33 261,481,599,653,692,759,795,1119,1798,2128,2151,2394,3272,3668,3747,4689,4950,5149,5901,6120,6224,6278,6317,6384,6421,6742,7498,7829,7852,8095,8984,9380,9458,	
limitado 2 693 2 259,5899,	
número 2 693 2 258,5898,	
Valor 2 693 2 3580,9292,	
basada 2 693 2 255,5895,	
recomendación 2 693 2 253,5893,	
Esta 3 693 3 252,5892,7173,	
lugar 17 693 17 247,314,901,1614,2850,3892,4063,4183,4285,4866,5359,5887,5954,6525,7314,8551,9605,	
tenga 2 693 2 246,5886,	
2) 6 693 6 489,986,5135,5235,6128,6609,	
virológica 7 693 7 242,1268,3378,4033,5882,6891,9091,	
recaída 4 693 4 241,3377,5881,9090,	
riesgo 11 693 11 239,1155,1377,1457,1823,5398,5879,6778,7000,7081,7523,	
reducir 5 693 5 237,1455,5118,5877,7079,	
HBeAc) 3 693 3 232,4713,5872,	
detección 9 693 9 230,2734,2765,3706,4711,5870,8433,8466,9417,	
VHB 75 693 75 228,311,330,353,406,856,877,898,919,927,982,1076,1270,1278,2561,2720,2773,2866,2884,3057,3134,3200,3294,3443,3699,3786,3817,3879,3901,3930,3957,4005,4024,4071,4149,4192,4258,4281,4322,4492,4578,4709,4752,5868,5951,5970,5992,6045,6480,6501,6522,6543,6551,6605,6699,6893,6901,8261,8420,8474,8567,8585,8761,8818,8844,8911,9006,9155,9410,9497,9530,9592,9614,9643,9670,	
ADN 46 693 46 226,328,854,917,1074,1276,2566,2604,2618,2646,2666,2675,2684,2718,2771,3055,3132,3697,3784,3955,4069,4190,4256,4490,4576,4707,5866,5968,6478,6541,6697,6899,8266,8304,8318,8346,8366,8375,8384,8418,8472,8759,8842,9408,9495,9668,	
(pérdida 5 693 5 222,2761,4703,5862,8462,	
seroconversión 24 693 24 219,249,290,2758,2838,2987,3016,3330,3356,3369,3391,4548,4700,5859,5889,5930,8459,8539,8690,8720,9043,9069,9082,9104,	
confirme 2 693 2 217,5857,	
después 12 693 12 213,1243,1292,2424,3458,4272,4727,5853,6866,6915,8125,9170,	
meses 14 693 14 212,848,862,1048,1242,1895,4388,4778,5852,6472,6486,6671,6865,7595,	
3-6 2 693 2 211,5851,	
durante 33 693 33 208,340,1044,1187,1222,1238,1290,1891,2176,2706,2828,3207,3235,3971,4059,4179,4247,4580,4776,5848,5979,6667,6810,6845,6861,6913,7591,7877,8406,8529,8918,8947,9685,	
positivos 8 693 8 203,300,2696,3691,5841,5940,8396,9403,	
HBeAg 45 693 45 202,221,224,271,299,302,806,859,2695,2760,2763,2840,2989,3018,3110,3332,3393,3665,3680,3690,3757,4140,4550,4702,4705,5840,5861,5864,5911,5939,5942,6432,6483,8395,8461,8464,8541,8692,8722,9045,9106,9377,9392,9402,9468,	
(HBC) 2 693 2 201,5839,	
pacientes 185 693 185 196,268,295,344,379,409,428,501,523,557,602,656,700,768,786,805,830,890,921,988,1013,1132,1147,1170,1200,1283,1311,1362,1445,1735,1975,2005,2272,2289,2306,2345,2357,2413,2692,2726,2787,2833,2861,2879,2900,2910,2918,2931,2959,2981,3021,3033,3051,3118,3188,3216,3288,3311,3366,3395,3411,3445,3472,3479,3505,3515,3533,3554,3662,3677,3687,3696,3737,3756,3795,3809,3811,3838,3908,3943,3999,4016,4090,4112,4136,4214,4220,4345,4354,4370,4425,4480,4517,4559,4569,4617,4771,5099,5122,5156,5188,5222,5404,5834,5908,5935,5983,6018,6048,6067,6140,6162,6183,6227,6281,6325,6393,6412,6431,6454,6514,6545,6611,6636,6755,6770,6793,6823,6906,6934,6985,7069,7103,7131,7435,7676,7706,7973,7990,8007,8046,8058,8114,8392,8425,8488,8534,8562,8580,8601,8612,8620,8633,8662,8684,8725,8737,8755,8828,8898,8927,9000,9023,9079,9108,9124,9157,9184,9191,9217,9227,9245,9266,9374,9389,9399,9407,9448,9467,9506,9522,9524,9551,9621,9656,	
En 49 693 49 195,267,294,343,888,920,1198,1360,2271,2288,2428,2624,2860,2974,3067,3287,3309,3357,3410,3444,3484,3810,3837,4010,4235,5187,5833,5907,5934,5982,6512,6544,6821,6983,7972,7989,8130,8324,8561,8677,8771,8999,9021,9070,9123,9156,9196,9523,9550,	
Duración 2 693 2 191,5829,	
alimentos 4 693 4 190,4864,4907,5828,	
administrarse 6 693 6 186,205,1684,5824,5843,7384,	
día 11 693 11 183,579,1354,4051,4171,4650,4677,4839,5821,6204,6977,	
vez 9 693 9 181,577,4049,4169,4648,4675,4837,5819,6202,	
recomendada 4 693 4 173,771,5811,6396,	
dosis 29 693 29 172,521,536,566,626,643,698,1340,1666,2380,4644,4670,4693,4830,4939,5120,5254,5267,5356,5810,6160,6192,6251,6268,6323,6963,7139,7366,8081,	
Adultos 2 693 2 170,5808,	
experiencia 2 693 2 161,5799,	
ensayo; 2 693 2 3708,9419,	
médico 2 693 2 159,5797,	
iniciado 2 693 2 156,5794,	
debe 14 693 14 154,204,354,518,541,948,1337,5792,5842,5993,6157,6475,6572,6960,	
El 11 693 11 150,2823,2914,3923,4972,5037,5081,5788,8524,8616,9636,	
x 16 693 16 3123,3130,3586,3595,3604,3617,3623,3627,8833,8840,9298,9307,9316,9329,9335,9339,	
efecto 7 693 7 1643,1701,2613,5212,7343,7401,8313,	
administración 16 693 16 149,761,1622,1890,1905,2371,4810,4860,4987,5243,5787,6386,7322,7590,7605,8072,	
Posología 2 693 2 145,5783,	
descompensada 6 693 6 142,383,4146,4218,5780,6022,	
fibrosis 10 693 10 138,2812,2857,2890,4358,4378,5776,8513,8558,8591,	
HBsAg 5 693 5 251,292,4290,5891,5932,	
o 61 693 61 137,188,243,359,414,609,719,791,937,941,953,967,1182,1291,1323,1332,1609,1649,2185,2421,2792,3059,3425,3429,3638,4139,4147,4360,4379,4445,4905,5431,5573,5721,5775,5826,5883,5997,6053,6234,6344,6417,6561,6565,6576,6590,6805,6914,6946,6955,7119,7121,7309,7349,7886,8122,8493,8763,9137,9141,9350,	
mayores 1 693 1 4684,	
activa 13 693 13 134,1159,1535,1561,1608,2533,5075,5772,6782,7235,7261,7308,8233,	
inflamación 6 693 6 132,2872,2940,5770,8573,8643,	
medicamentos 13 693 13 1484,1545,1573,1721,1742,1770,7184,7245,7273,7421,7442,7470,9702,	
histológica 4 693 4 130,3281,5768,8993,	
persistente 2 693 2 127,5765,	
elevados 4 693 4 124,3024,5762,8728,	
sérica 9 693 9 123,843,913,1068,4978,5761,6467,6537,6691,	
(ALT) 2 693 2 122,5760,	
aminotransferasa 2 693 2 121,5759,	
alanina 2 693 2 120,5758,	
(19%) 2 693 2 3592,9304,	
niveles 34 693 34 118,338,840,2946,3023,3035,3053,3063,3546,3777,3835,3859,3953,3963,3969,4101,4852,5370,5444,5756,5977,6464,8649,8727,8739,8757,8767,9258,9488,9548,9572,9666,9676,9683,	
viral 10 693 10 117,1158,2559,2567,3743,5755,6781,8259,8267,9454,	
replicación 8 693 8 116,1157,2716,3742,5754,6780,8416,9453,	
fertilidad 1 693 1 5428,	
evidencia 7 693 7 114,129,3947,5418,5752,5767,9660,	
laminados 1 693 1 5555,	
compensada 9 693 9 112,750,2700,4028,4376,4608,5750,6375,8400,	
hepática 48 693 48 111,133,141,382,651,659,664,689,703,932,1036,1150,1167,1218,1289,2332,2699,2873,2941,3981,4027,4145,4206,4217,4223,5147,5168,5280,5749,5771,5779,6021,6276,6284,6289,6314,6328,6556,6659,6773,6790,6841,6912,8033,8399,8574,8644,9695,	
Enfermedad 4 693 4 110,140,5748,5778,	
· 12 693 12 109,139,194,266,293,370,5747,5777,5832,5906,5933,6009,	
adultos 8 693 8 107,1499,3574,4759,4801,5745,7199,9286,	
crónica 15 693 15 105,169,200,749,1393,1979,2293,4374,5743,5807,5838,6374,7016,7680,7994,	
<5 2 693 2 589,6222,	
B 32 693 32 104,168,199,748,943,1214,1392,1397,1413,1438,1465,1978,2292,2366,2502,4373,4637,5742,5806,5837,6373,6567,6837,7015,7021,7037,7062,7089,7679,7993,8067,8202,	
hepatitis 52 693 52 103,167,198,439,747,789,792,866,906,942,993,1059,1137,1175,1213,1391,1396,1412,1437,1464,1977,2225,2291,2365,2501,4372,4636,5741,5805,5836,6078,6372,6415,6418,6490,6530,6566,6616,6682,6760,6798,6836,7014,7020,7036,7061,7088,7678,7926,7992,8066,8201,	
(23/209 2 693 2 4493,4540,	
tratamiento 110 693 110 100,151,164,193,207,281,287,342,377,424,826,869,964,1009,1090,1128,1140,1179,1189,1224,1234,1245,1294,1309,1329,1373,1388,1420,1449,1931,2212,2363,2440,2459,2705,2824,2978,3002,3040,3066,3346,3373,3424,3455,3509,3529,3725,3730,3753,3767,3886,3940,4053,4173,4211,4329,4384,5407,5738,5789,5802,5831,5845,5921,5927,5981,6016,6063,6450,6493,6587,6632,6713,6751,6763,6802,6812,6847,6857,6868,6917,6932,6952,6996,7011,7044,7073,7631,7913,8064,8142,8161,8405,8525,8681,8705,8744,8770,9059,9086,9136,9167,9221,9241,9436,9441,9464,9478,9599,9653,	
indicado 6 693 6 97,1054,1303,5735,6677,6926,	
está 12 693 12 96,254,459,770,3931,4802,5652,5734,5894,6098,6395,9644,	
trimetoprima 4 693 4 1570,1648,7270,7348,	
terapéuticas 4 693 4 94,4831,4940,5732,	
Indicaciones 2 693 2 93,5731,	
/ 2 693 2 136,5774,	
	4 2 693 2 91,5729,	
CLÍNICOS 2 693 2 90,5728,	
DATOS 3 693 3 89,5489,5727,	
4 46 693 46 88,143,443,612,712,725,726,985,1477,1478,1790,1900,1939,1963,2208,2250,2367,3147,3260,3919,4008,4073,4194,5134,5234,5520,5726,5781,6082,6237,6337,6350,6351,6608,7149,7178,7490,7600,7640,7664,7909,7951,8068,8857,8972,9632,	
" 1 693 1 87,	
cara 1 693 1 86,	
CG5"" 1 693 1 83,	
""GX 1 693 1 82,	
marcados 1 693 1 81,	
biconvexos 1 693 1 79,	
cápsulas 1 693 1 78,	
forma 18 693 18 76,126,147,684,835,1696,2532,2672,2713,4774,5764,5785,6309,6459,7396,8232,8372,8413,	
película 1 693 1 74,	
recubiertos 1 693 1 72,	
caramelo 1 693 1 71,	
color 2 693 2 70,5723,	
Comprimidos 1 693 1 68,	
11 2 693 2 4666,5392,	
	"Comprimidos 1 693 1 64,	
FARMACÉUTICA 2 693 2 63,5716,	
FORMA 2 693 2 62,5715,	
3 31 693 31 61,713,823,847,1094,3143,3247,3285,3487,3562,3594,3646,4085,4436,4453,4926,5047,5237,5513,5517,5714,6338,6471,6717,8853,8959,8997,9199,9274,9306,9358,	
6 22 693 22 59,861,1241,1791,2476,3139,3258,4074,4195,5488,5507,5512,5519,5532,5560,5561,5712,6485,6864,7491,8849,8970,	
sección 27 693 27 58,263,367,417,442,487,774,984,1708,1817,1899,2249,4007,5133,5233,5711,5903,6005,6056,6081,6126,6399,6607,7408,7517,7599,7950,	
mostraron 7 693 7 2936,3820,3844,5482,8638,9533,9557,	
ver 4 693 4 57,1998,5710,7699,	
excipientes 4 693 4 56,724,5495,6349,	
completa 4 693 4 54,1519,5709,7219,	
lista 2 693 2 53,5708,	
Para 6 693 6 51,1077,1307,5706,6700,6930,	
lamivudina 131 693 131 50,321,495,597,629,678,736,763,784,803,883,1130,1181,1331,1342,1385,1422,1451,1527,1591,1620,1632,1668,1686,1706,1737,1804,1844,1907,1933,2013,2074,2218,2314,2360,2384,2449,2650,2710,2827,3348,3375,3428,3476,3558,3675,3732,3761,3890,4038,4058,4094,4124,4178,4244,4271,4386,4406,4475,4525,4562,4572,4601,4717,4796,4862,4887,4900,4914,4958,4980,5014,5042,5093,5108,5139,5178,5194,5219,5245,5381,5394,5476,5691,5961,6134,6254,6303,6361,6388,6410,6429,6507,6753,6804,6954,6965,7008,7046,7075,7227,7291,7320,7332,7368,7386,7406,7437,7504,7544,7607,7633,7714,7775,7919,8015,8061,8085,8151,8350,8410,8528,9061,9088,9140,9188,9270,9387,9443,9472,9603,	
contienen 1 693 1 46,	
cuenta 2 693 2 2160,7861,	
Zeffix 26 693 26 45,95,153,175,184,426,457,543,555,568,828,966,1011,1785,5733,5791,5813,5822,6065,6096,6181,6194,6452,6589,6634,7485,	
	Los 1 693 1 39,	
CUANTITATIVA 2 693 2 38,5683,	
Y 2 693 2 37,5682,	
CUALITATIVA 2 693 2 36,5681,	
COMPOSICIÓN 2 693 2 35,5680,	
temprana 1 693 1 5436,	
2 34 693 34 34,144,740,1710,2795,2829,3070,3087,3129,3243,3568,3585,3603,3616,3626,4623,4664,4780,5508,5679,5782,6365,7410,8496,8530,8774,8790,8839,8955,9280,9297,9315,9328,9338,	
pelicular 4 693 4 33,43,67,5547,	
cubierta 4 693 4 32,42,66,5546,	
comprimidos 3 693 3 30,40,5544,	
mg 15 693 15 29,48,179,540,1627,4044,4056,4164,4176,4656,4673,4835,5817,7144,7327,	
100 10 693 10 28,47,178,539,4055,4175,4655,4672,4834,5816,	
	Zeffix 3 693 3 27,5674,5684,	
MEDICAMENTO 4 693 4 26,2474,5673,8176,	
NOMBRE 2 693 2 24,5671,	
1 31 693 31 22,23,60,92,548,552,1099,2478,2707,2745,3122,3203,3257,4299,4846,4925,5492,5670,5713,5730,5905,6174,6178,6401,6722,8178,8407,8446,8832,8913,8969,	
PRODUCTO 1 693 1 21,	
DEL 4 693 4 20,25,5644,5672,	
grupo 3 693 3 4472,4522,4536,	
CARACTERÍSTICAS 1 693 1 19,	
LAS 1 693 1 18,	
DE 10 693 10 17,2472,5587,5590,5606,5608,5614,5618,5641,8174,	
RESUMEN 1 693 1 16,	
O 1 693 1 15,	
absorción 1 693 1 7115,	
TÉCNICA 1 693 1 14,	
FICHA 1 693 1 13,	
tuvo 2 693 2 2158,7859,	
información 6 693 6 10,1079,1402,5647,6702,7026,	
Toda 1 693 1 8,	
medicamento 4 693 4 7,12,5651,7129,	
Basica 1 693 1 5,	
	Información 1 693 1 4,	
COMPRIMIDOS 1 693 1 3,	
28 2 693 2 2,5541,	
100MG 1 693 1 1,	
Trombocitopenia 2 693 2 2198,7899,	
ZEFFIX 1 693 1 0,	
